DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Conroy T, Hammel P, Hebbar M, Abdelghani M, Wei A, Raoul J, Chone L. et al.
Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
J Clin Oncol 2018;
36 (suppl):abstr LBA4001
Access:
We do not assume any responsibility for the contents of the web pages of other providers.